Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle
Open Access

Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis

Arthur Kavanaugh, Philip J. Mease, Juan J. Gomez-Reino, Adewale O. Adebajo, Jürgen Wollenhaupt, Dafna D. Gladman, Marla Hochfeld, Lichen L. Teng, Georg Schett, Eric Lespessailles and Stephen Hall
The Journal of Rheumatology March 2015, 42 (3) 479-488; DOI: https://doi.org/10.3899/jrheum.140647
Arthur Kavanaugh
From the University of California, San Diego School of Medicine, La Jolla, California; Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Celgene Corporation, Summit, New Jersey, USA; University of Sheffield, Sheffield, UK; Hospital Clinico Universitario, Santiago, Spain; Schön Klinik Hamburg Eilbek, Hamburg; University of Erlangen-Nuremberg, Erlangen, Germany; Toronto Western Research Institute, Toronto, Ontario, Canada; University of Orléans, Orléans, France; and the Monash University, Cabrini Health Australia, Melbourne, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: akavanaugh@ucsd.edu
Philip J. Mease
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan J. Gomez-Reino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adewale O. Adebajo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Wollenhaupt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dafna D. Gladman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marla Hochfeld
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lichen L. Teng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georg Schett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Lespessailles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Hall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 42 no. 3 479-488
DOI 
https://doi.org/10.3899/jrheum.140647
PubMed 
25593233

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication October 20, 2014
  • Published online March 1, 2015.

Article Versions

  • Latest version (January 15, 2015 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2015 Free online via JRheum Full Release option

Author Information

  1. Arthur Kavanaugh⇑,
  2. Philip J. Mease,
  3. Juan J. Gomez-Reino,
  4. Adewale O. Adebajo,
  5. Jürgen Wollenhaupt,
  6. Dafna D. Gladman,
  7. Marla Hochfeld,
  8. Lichen L. Teng,
  9. Georg Schett,
  10. Eric Lespessailles and
  11. Stephen Hall
  1. From the University of California, San Diego School of Medicine, La Jolla, California; Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Celgene Corporation, Summit, New Jersey, USA; University of Sheffield, Sheffield, UK; Hospital Clinico Universitario, Santiago, Spain; Schön Klinik Hamburg Eilbek, Hamburg; University of Erlangen-Nuremberg, Erlangen, Germany; Toronto Western Research Institute, Toronto, Ontario, Canada; University of Orléans, Orléans, France; and the Monash University, Cabrini Health Australia, Melbourne, Australia.
  2. A. Kavanaugh, MD, Division of Rheumatology, Allergy and Immunology, University of California; P.J. Mease, MD, Swedish Hospital Clinical Research Division, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; J.J. Gomez-Reino, MD, PhD, Rheumatology Service, Department of Medicine, Hospital Clinico Universitario; A.O. Adebajo, MD, FRCP, Professor of Rheumatology, Faculty of Medicine, Dentistry and Health, University of Sheffield; Prof. Dr. med. J. Wollenhaupt, Schön Klinik Hamburg Eilbek, Klinik für Rheumatologie; D.D. Gladman, MD, FRCPC, Division of Health Care and Outcomes Research, Toronto Western Research Institute; M. Hochfeld, MD; L.L. Teng, PhD, Celgene Corporation; Prof. Dr. med. G. Schett, Department of Internal Medicine, University of Erlangen-Nuremberg; E. Lespessailles, MD, PhD, University of Orléans; S. Hall, MBBS, FRACP, Associate Professor of Medicine, Monash University, Cabrini Health Australia.
  1. Address correspondence to Dr. A. Kavanaugh, Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California, San Diego, 9500 Gilman Drive, Mail Code 0943, La Jolla, California 92093-0942, USA. E-mail: akavanaugh{at}ucsd.edu

Article usage

Article usage: January 2015 to April 2022

AbstractFullPdf
Jan 20154613443
Feb 201529018551
Mar 20151032422629
Apr 2015221299355
May 2015176249271
Jun 201592190231
Jul 2015100180174
Aug 201596151162
Sep 201575185169
Oct 201590171173
Nov 201573129115
Dec 20151209080
Jan 20164610999
Feb 201667113121
Mar 201698117136
Apr 201651120136
May 20164412193
Jun 20165697151
Jul 20164290100
Aug 2016537299
Sep 20164187104
Oct 20165611797
Nov 201667110115
Dec 20166010370
Jan 2017229967
Feb 2017209782
Mar 20171619679
Apr 20172012578
May 201714112115
Jun 20171218664
Jul 2017109257
Aug 2017167762
Sep 2017154371
Oct 20172790104
Nov 201728102102
Dec 201786865
Jan 2018188964
Feb 201879170
Mar 20181889108
Apr 201814103119
May 20181578100
Jun 2018166482
Jul 2018166471
Aug 2018135467
Sep 2018165680
Oct 2018186172
Nov 2018155849
Dec 2018135949
Jan 201995753
Feb 2019236938
Mar 2019164852
Apr 2019103353
May 201956561
Jun 2019115460
Jul 201964361
Aug 201945758
Sep 201914857
Oct 201965655
Nov 2019155869
Dec 2019127663
Jan 2020196243
Feb 2020226427
Mar 2020125836
Apr 202066170
May 20201111469
Jun 202055440
Jul 202048252
Aug 202062432
Sep 202075042
Oct 202076552
Nov 202056339
Dec 2020411542
Jan 202167227
Feb 202196020
Mar 202185823
Apr 202134724
May 202176920
Jun 202165017
Jul 202124319
Aug 2021310438
Sep 202128025
Oct 202144531
Nov 202124338
Dec 202123716
Jan 202256092
Feb 202215016
Mar 2022310028
Apr 202288635

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 42, Issue 3
1 Mar 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis
Arthur Kavanaugh, Philip J. Mease, Juan J. Gomez-Reino, Adewale O. Adebajo, Jürgen Wollenhaupt, Dafna D. Gladman, Marla Hochfeld, Lichen L. Teng, Georg Schett, Eric Lespessailles, Stephen Hall
The Journal of Rheumatology Mar 2015, 42 (3) 479-488; DOI: 10.3899/jrheum.140647

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis
Arthur Kavanaugh, Philip J. Mease, Juan J. Gomez-Reino, Adewale O. Adebajo, Jürgen Wollenhaupt, Dafna D. Gladman, Marla Hochfeld, Lichen L. Teng, Georg Schett, Eric Lespessailles, Stephen Hall
The Journal of Rheumatology Mar 2015, 42 (3) 479-488; DOI: 10.3899/jrheum.140647
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • APPENDIX 1.
    • APPENDIX 2.
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

APREMILAST
PHOSPHODIESTERASE 4 INHIBITOR
PSORIATIC ARTHRITIS
SAFETY
TREATMENT EFFICACY

Related Articles

Cited By...

More in this TOC Section

  • Vasculitis: What Have We Learned in the Last 50 Years?
  • Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)–associated Bronchiectasis: Role of RA-related Autoantibodies
  • Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Show more Article

Similar Articles

Keywords

  • apremilast
  • PHOSPHODIESTERASE 4 INHIBITOR
  • psoriatic arthritis
  • safety
  • treatment efficacy

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire